Procter & Gamble Company (The) $PG Shares Sold by Cerity Partners LLC

Cerity Partners LLC trimmed its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 0.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,117,187 shares of the company’s stock after selling 27,542 shares during the quarter. Procter & Gamble accounts for 1.3% of Cerity Partners LLC’s holdings, making the stock its 13th largest holding. Cerity Partners LLC owned about 0.26% of Procter & Gamble worth $876,656,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. boosted its position in shares of Procter & Gamble by 1,000.0% during the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock worth $25,000 after acquiring an additional 150 shares in the last quarter. Park Square Financial Group LLC boosted its position in shares of Procter & Gamble by 65.1% during the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after acquiring an additional 71 shares in the last quarter. Evolution Wealth Management Inc. boosted its position in shares of Procter & Gamble by 1,315.4% during the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock worth $26,000 after acquiring an additional 171 shares in the last quarter. Maseco LLP acquired a new position in shares of Procter & Gamble during the 4th quarter worth about $28,000. Finally, Saranac Partners Ltd acquired a new position in shares of Procter & Gamble during the 3rd quarter worth about $30,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Down 1.0%

Shares of NYSE PG opened at $145.09 on Tuesday. The stock has a market cap of $337.86 billion, a PE ratio of 21.21, a price-to-earnings-growth ratio of 6.29 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The business has a 50-day moving average price of $144.24 and a 200 day moving average price of $147.68.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.56 by $0.03. The firm had revenue of $21.24 billion during the quarter, compared to analysts’ expectations of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The business’s revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were paid a dividend of $1.0885 per share. The ex-dividend date of this dividend was Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s dividend payout ratio (DPR) is currently 63.60%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on PG. Bank of America lowered their price objective on Procter & Gamble from $171.00 to $167.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Wells Fargo & Company upped their price objective on Procter & Gamble from $158.00 to $164.00 and gave the stock an “overweight” rating in a research report on Monday, April 27th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research report on Friday, March 27th. UBS Group upped their target price on Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, April 27th. Finally, Piper Sandler upped their target price on Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Friday, April 24th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $161.06.

Read Our Latest Analysis on PG

About Procter & Gamble

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.